CNS Pharmaceuticals CEO John Climaco's 2020 pay jumps 28% to $1.6M

CNS Pharmaceuticals reports 2020 executive compensation

By ExecPay News

Published: June 7, 2021

CNS Pharmaceuticals reported fiscal year 2020 executive compensation information on June 7, 2021.
In 2020, three executives at CNS Pharmaceuticals received on average a compensation package of $902K, a 2% increase compared to previous year.
Average pay of disclosed executives at CNS Pharmaceuticals
John Climaco, Chief Executive Officer, received $1.6M in total, which increased by 28% compared to 2019. 60% of Climaco's compensation, or $938K, was in option awards. Climaco also received $195K in non-equity incentive plan and $440K in salary.
Christopher Downs, Chief Financial Officer, received a compensation package of $791K, which decreased by 31% compared to previous year. 50% of the compensation package, or $396K, was in option awards.
Sandra Silberman, Chief Medical Officer, earned $341K in 2020, a 25% increase compared to previous year.

Related executives

John Climaco

CNS Pharmaceuticals

Chief Executive Officer

Christopher Downs

CNS Pharmaceuticals

Chief Financial Officer

Sandra Silberman

CNS Pharmaceuticals

Chief Medical Officer

You may also like

Source: SEC filing on June 7, 2021.